Skip to content
FREE LIVE WEBINAR FOR PRACTITIONERS AND COACHES

Your Client Wants to Try Ibogaine. Where Does Your Role Begin and End?

Join Paul F. Austin, Jonathan Dickinson, CEO & co-founder of Ambio, and Beth Sparks, a licensed therapist who leads Ambio’s preparation and integration team, to learn who shouldn’t do ibogaine, how to judge a treatment provider, and how to prepare and integrate clients, all within your scope as a practitioner.
Paul F. Austin
Paul F.
Austin
Jonathan
Dickinson
Beth Sparks
Beth
Sparks
Tuesday, November 24, 10 AM PT / 1 PM ET / 6 PM UK
60 minutes | Live Q&A with Paul, Jonathan and Beth
Can’t make it live? Register anyway: the replay is free to watch for 48 hours, then $19.
Ibogaine is everywhere… but it isn’t for everyone.

Over the last 18 months, there have been a number of big news items for ibogaine:

  • In April 2026, an executive order was issued to speed up FDA review¹.
  • In June 2025, $50 million was designated for research in Texas².
  • Dozens, if not hundreds, of veterans and former athletes have openly shared their stories.

As interest grows, more of your clients will consider treatment abroad. But ibogaine carries real cardiac risk, interacts with many common medications, and can mean a day or more in one of the most demanding experiences in psychedelics.

Preparation and Integration is where you come in.

Clients don’t arrive at an ibogaine clinic out of nowhere. The decision usually starts months earlier, in a conversation with someone they trust. And when they come home, the window for change may stay open far longer than after other psychedelics. The clinic handles the treatment, but the weeks before and the months after are where your work comes into play.

Sound familiar?
“A client told me they’re booking ibogaine abroad. I don’t know what to ask, or whether I should say anything at all.”

“I’ve heard ibogaine can be risky for the heart. I don’t want to be the one who said ‘sounds great’ and then something went wrong.”

“I know how to support integration after psilocybin. I have no idea if the same approach works after ibogaine.”

This webinar answers all three. It also draws one clear line that all practitioners must follow: never source, supply, or administer ibogaine, and screening and treatment stay with the clinic’s medical team. Your work is the conversation before and the support after.
Why this one is personal for Paul
Paul first heard about iboga in 2016, at the Global Ibogaine Conference in Mexico. It was his first psychedelic conference, and it’s where he met Jonathan. It took him about 10 years to feel ready to work with iboga himself, at a retreat in Baja, Mexico.

“Iboga is not a psychedelic that I would casually encourage just anyone to take. In fact, it was one of the most demanding experiences that I’ve ever had, and for me, that discomfort was part of the medicine.” – Paul F. Austin, on The Psychedelic Podcast³

He says the experience gave him a very personal understanding of why this medicine needs such a careful container. That’s the lens he and Jonathan bring to this webinar.

What You'll Learn:

Who shouldn’t do ibogaine, including the cardiac and medication red flags to watch for
The questions to ask any treatment provider before a client books
How to prepare a client in the weeks before treatment
What preparation and integration look like in practice, from Beth, who leads the team that prepares Ambio’s clients for ibogaine and supports their integration
Why integration after ibogaine differs from integration after psilocybin
Where your role begins and ends, so you can support clients without stepping outside your scope
What Jonathan learned from more than 10 years in the Bwiti tradition of Gabon about respect, reciprocity and care

Free Gift for Live Attendees:

The Practitioner’s Ibogaine Readiness Guide
A practical guide with the screening red flags to refer out, 10 questions to ask any treatment provider, and a pre-treatment preparation checklist. Yours when you join live, sent to you after the session.

Perfect For:

Perfect For:

Coaches & Wellness Practitioners
who want to answer ibogaine questions confidently while protecting their reputation and staying within legal scope
Medical Professionals
whose patients are asking about ibogaine and who want a clear view of the risks, the right provider questions and aftercare
Aspiring Practitioners
building a psychedelic practice who want a clear, ethical place to start
Therapists & Psychologists
supporting clients who come back from ibogaine with a lot to integrate
Psychedelic Guides & Facilitators
who want to understand how ibogaine differs from the medicines they already work with

Your Host: Paul F. Austin

Your Host: Paul F. Austin

Paul F. Austin is the founder of Third Wave and the Psychedelic Coaching Institute, which has trained more than 250 practitioners. He wrote Mastering Microdosing and hosts The Psychedelic Podcast, with over 5 million downloads. His work has been featured in Bloomberg, Rolling Stone, Inc., and the BBC’s Worklife.

Paul treats psychedelic use as a refined skill, one cultivated through intention, mentorship, and courageous exploration. As Lead Trainer of all Psychedelic Coaching Institute programs, he trains practitioners to support clients with skill, and within their scope.

Special Guest:
Jonathan Dickinson

Special Guest: Jonathan Dickinson

Jonathan Dickinson is the CEO and co-founder of Ambio Life Sciences and one of the world’s leading experts on ibogaine, with more than 15 years of experience in clinical care, traditional practice and psychedelic research. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he wrote the field’s foundational safety guidelines and has co-authored peer-reviewed research on ibogaine’s potential for people with trauma, traumatic brain injury, pain, multiple sclerosis and Parkinson’s.

Jonathan was initiated into two branches of the Bwiti tradition in Gabon: Dissoumba (Fang) in 2014 and Missoko in 2022. He holds the first active export license for iboga root and led the first export of iboga from Gabon under the Nagoya Protocol, the international agreement that requires fair benefit-sharing with the communities a plant comes from. His book, Ibogaine and the Bicameral Mind, came out in September 2026 with a foreword by former Texas governor Rick Perry. He is also on the faculty of the Psychedelic Practitioner Certification.

Special Guest:
Beth Sparks

Beth Sparks

Special Guest: Beth Sparks

Beth Sparks, a licensed clinical social worker, is Head Integration Coach at Ambio Life Sciences. She leads a 25-person team that supports clients through preparation before ibogaine and 5-MeO-DMT treatment and integration afterward. Her focus is helping clients get ready emotionally and practically for treatment, then turn what they experience into lasting change in their relationships, daily lives and well-being. Beth guides coaches on readiness, trauma-informed communication and client complexity. She also works with Ambio’s medical, intake, hosting and leadership teams so care stays consistent from the first conversation through life after treatment. She brings to this work her experience as a trauma-focused psychotherapist, a Certified EMDR (Eye Movement Desensitization and Reprocessing) Therapist and a Marine Corps veteran.

Live Q&A Session

Get your specific questions answered during our interactive Q&A session with Paul, Jonathan and Beth

ABOUT US

Why Learn From the Psychedelic Coaching Institute?

Now the gold standard in professional psychedelic training, we have taught hundreds of practitioners to master the skill of psychedelics since 2021.


Founder Paul F. Austin recognized a critical gap: more and more well-meaning people were interested in becoming practitioners, but few had the education, hands-on training, ethical clarity, and marketability to become credible and make a positive impact.

The Psychedelic Coaching Institute came into existence to close this gap by training the next generation of psychedelic leaders. We grew from our sister company, Third Wave, which has been a trusted resource for psychedelic education for 10+ years.

Today, we blend science, spirit, and skill to give our certified practitioners a comprehensive toolkit for preparation, facilitation, and integration. Paul’s expertise in intentional microdosing, in particular, guides many of our core methodologies.

We offer two flagship programs:
Rooted in a nervous system-first approach and equipped with entrepreneurial gusto, Psychedelic Coaching Institute practitioners are defining the future of this third wave of psychedelics.



Will you join us for this accessible entrance into your psychedelic career?